MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3

Tumor Biology

Volumn 39, Issue 6, 2017, Pages

  Zhong, Lou ^a,b   Sun, Siyuan ^b   Shi, Jiahai ^b   Cao, Fei ^b   Han, Xiao ^b   Chen, Zhong ^a,b  

^a Suzhou University   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Lung cancer; Migration; MiR 125a 5p; STAT3

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MICRORNA; MICRORNA 125A 5P; STAT3 PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN125 MICRORNA, HUMAN; STAT3 PROTEIN, HUMAN;

A-549 CELL LINE; APOPTOSIS; ARTICLE; BIOLOGICAL TRAIT; BRDU ASSAY; BRONCHIAL EPITHELIAL CELL; CANCER THERAPY; CANCER TISSUE; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FILTERS AND MEMBRANES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HCC827 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOMA CELL LINE; NCI-H1299 CELL LINE; PLA-801D CELL LINE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; 3' UNTRANSLATED REGION; BIOSYNTHESIS; CELL MOTION; GENETICS; LUNG TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; A549 CELLS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 85028504989     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1177/1010428317697579     Document Type: Article

References (51)

1. Kolahian S, Oz HH, Zhou B, et al. The emerging role of myeloid-derived suppressor cells in lung diseases. Eur Respir J 2016; 47: 967-977.
2. Zhou C and Yao LD. Strategies to improve outcomes of patients with EGRF-mutant non-small cell lung cancer: review of the literature. J Thorac Oncol 2016; 11: 174-186.
3. Bremnes RM, Busund LT, Kilvaer TL, et al. The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer. J Thorac Oncol 2016; 11: 789-800.
4. Giangreco A, Groot KR and Janes SM. Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med 2007; 175: 547-553.
5. Mucchietto V, Crespi A, Fasoli F, et al. Neuronal acetylcholine nicotinic receptors as new targets for lung cancer treatment. Curr Pharm Des 2016; 22: 2160-2169.
6. Parikh M, Riess J and Lara PN Jr. New and emerging developments in extensive-stage small cell lung cancer therapeutics. Curr Opin Oncol 2016; 28: 97-103.
7. Sheikhbahaei S, Mena E, Marcus C, et al. 18F-FDG PET/ CT: therapy response assessment interpretation (Hopkins criteria) and survival outcomes in lung cancer patients. J Nucl Med 2016; 57: 855-860.
8. Xie J and Zhang X. The impact of genomic profiling for novel cancer therapy—recent progress in non-small cell lung cancer. J Genet Genomics 2016; 43: 3-10.
9. Falcon-Rodriguez CI, Osornio-Vargas AR, Sada-Ovalle I, et al. Aeroparticles, composition, and lung diseases. Front Immunol 2016; 7: 3.
10. Guo H, Nan Y, Zhen Y, et al. MiRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1. Tumour Biol 2016; 37: 13751-13761.
11. Petrosyan KG and Hu CK. Noise-induced multistability in the regulation of cancer by genes and pseudogenes. J Chem Phys 2016; 145: 045102.
12. Powdrill MH, Desrochers GF, Singaravelu R, et al. The role of microRNAs in metabolic interactions between viruses and their hosts. Curr Opin Virol 2016; 19: 71-76.
13. Li L, Piontek K, Ishida M, et al. Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model. Hepatology 2016; 65: 501-514.
14. Yao M, Gao W, Yang J, et al. The regulation roles of miR-125b, miR-221 and miR-27b in porcine salmonella infection signaling pathway. Biosci Rep 2016; 36: e00375.
15. Lai L, Azzam KM, Lin WC, et al. MicroRNA-33 regulates the innate immune response via ATP binding cassette transporter-mediated remodeling of membrane microdomains. J Biol Chem 2016; 291: 19651-19660.
16. Singh R, Ramasubramanian B, Kanji S, et al. Circulating microRNAs in cancer: hope or hype? Cancer Lett 2016; 381: 113-121.
17. Jiang Z, Wang H, Li Y, et al. Mir-129-5p is down-regulated and involved in migration and invasion of gastric cancer cells by targeting interleukin-8. Neoplasma 2016; 63: 673-680.
18. Pal D, Mukhopadhyay D, Ramaiah MJ, et al. Regulation of cell proliferation and migration by miR-203 via GAS41/ miR-10b axis in human glioblastoma cells. PLoS ONE 2016; 11: e0159092.
19. Han L, Liu B, Jiang L, et al. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha. Tumour Biol 2016; 37: 13205-13214.
20. Liang T, Li L, Cheng Y, et al. MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12. Onco Targets Ther 2016; 9: 4307-4315.
21. Wu J, Yuan P, Mao Q, et al. MiR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA. Biochem Biophys Res Commun 2016; 478: 274-278.
22. Yanaihara N, Caplen N, Bowman E, et al. Unique micro-RNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198.
23. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103: 2257-2261.
24. Yin H, Sun Y, Wang X, et al. Progress on the relationship between miR-125 family and tumorigenesis. Exp Cell Res 2015; 339: 252-260.
25. Sun YM, Lin KY and Chen YQ. Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol 2013; 6: 6.
26. Scott GK, Goga A, Bhaumik D, et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 2007; 282: 1479-1486.
27. Guo X, Wu Y and Hartley RS. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol 2009; 6: 575-583.
28. Gower AC, Steiling K, Brothers JF 2nd, et al. Transcriptomic studies of the airway field of injury associated with smokingrelated lung disease. Proc Am Thorac Soc 2011; 8: 173-179.
29. Hassanein M, Rahman JS, Chaurand P, et al. Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc 2011; 8: 183-188.
30. Sundar IK, Mullapudi N, Yao H, et al. Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics. Curr Opin Pulm Med 2011; 17: 279-285.
31. Mizuno K, Mataki H, Seki N, et al. MicroRNAs in nonsmall cell lung cancer and idiopathic pulmonary fibrosis. J Hum Genet 2017; 62: 57-65.
32. Jang HJ, Lee HS, Burt BM, et al. Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer. Gut 2016; 66: 215-225.
33. Han J, Liu S, Zhang Y, et al. MiRSEA: discovering the pathways regulated by dysfunctional microRNAs. Oncotarget 2016; 7: 55012-55025.
34. Ui-Tei K, Nishi K, Takahashi T, et al. Thermodynamic control of small RNA-mediated gene silencing. Front Genet 2012; 3: 101.
35. Yang JS, Maurin T and Lai EC. Functional parameters of Dicer-independent microRNA biogenesis. RNA 2012; 18: 945-957.
36. Weiland M, Gao XH, Zhou L, et al. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 2012; 9: 850-859.
37. Yamamoto H, Adachi Y, Taniguchi H, et al. Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer. World J Gastroenterol 2012; 18: 2745-2755.
38. Du L and Pertsemlidis A. MicroRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opin Biol Ther 2012; 12: 1221-1239.
39. Yang J, Li G and Zhang K. Mir-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression. Biomed Pharmacother 2016; 80: 381-387.
40. Ceyzeriat K, Abjean L, Carrillo-de Sauvage MA, et al. The complex STATes of astrocyte reactivity: how are they controlled by the JAK-STAT3 pathway? Neuroscience 2016; 330: 205-218.
41. Hillmer EJ, Zhang H, Li HS, et al. STAT3 signaling in immunity. Cytokine Growth Factor Rev 2016; 31: 1-15.
42. Szelag M, Piaszyk-Borychowska A, Plens-Galaska M, et al. Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease. Oncotarget 2016; 7: 48788-48812.
43. Sala D and Sacco A. Signal transducer and activator of transcription 3 signaling as a potential target to treat muscle wasting diseases. Curr Opin Clin Nutr Metab Care 2016; 19: 171-176.
44. Zimmers TA, Fishel ML and Bonetto A. STAT3 in the systemic inflammation of cancer cachexia. Semin Cell Dev Biol 2016; 54: 28-41.
45. Liang Z, Wu G, Fan C, et al. The emerging role of signal transducer and activator of transcription 3 in cerebral ischemic and hemorrhagic stroke. Prog Neurobiol 2016; 137: 1-16.
46. Furtek SL, Backos DS, Matheson CJ, et al. Strategies and approaches of targeting STAT3 for cancer treatment. ACS Chem Biol 2016; 11: 308-318.
47. He N, Feng G, Li Y, et al. Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer. Stem Cell Res Ther 2016; 7: 95.
48. Chen B, Liang Y, He Z, et al. Autocrine activity of BDNF induced by the STAT3 signaling pathway causes prolonged TrkB activation and promotes human non-small-cell lung cancer proliferation. Sci Rep 2016; 6: 30404.
49. Meng J, Zhang XT, Liu XL, et al. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Cell Signal 2016; 28: 1673-1682.
50. Liu CC, Lin SP, Hsu HS, et al. Suspension survival mediated by PP2A-STAT3-Col XVII determines tumour initiation and metastasis in cancer stem cells. Nat Commun 2016; 7: 11798.
51. Grabner B, Moll HP and Casanova E. Unexpected oncosuppressive role for STAT3 in KRAS-induced lung tumorigenesis. Mol Cell Oncol 2016; 3: e1036199.